Filing Details

Accession Number:
0001127602-21-016063
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-05-10 13:00:00
Reporting Period:
2021-05-06
Accepted Time:
2021-05-10 16:31:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1082554 United Therapeutics Corp UTHR Pharmaceutical Preparations (2834) 521984749
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1231427 Christopher Patusky C/O United Therapeutics Corporation
1040 Spring Street
Silver Spring MD 20910
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-05-06 2,500 $63.90 4,800 No 4 M Direct
Common Stock Disposition 2021-05-06 2,500 $192.07 2,300 No 4 D Direct
Common Stock Disposition 2021-05-10 100 $190.52 1,200 No 4 S Indirect By Family Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 D Direct
No 4 S Indirect By Family Trust
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Share Tracking Award Disposition 2021-05-06 2,500 $0.00 2,500 $63.90
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
9,500 2014-06-26 2023-06-26 No 4 M Direct
Footnotes
  1. This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.